Collectively, these findings underscore the potential of lncRNAs, such as HOTAIR, NEAT1, and KCNQ1OT1, to influence immune checkpoints and improve the efficacy of immunotherapy in CRC patients. The gene discussed is KCNQ1OT1; the disease is colorectal carcinoma.